Deficient LAR expression decreases basal forebrain cholinergic neuronal size and hippocampal cholinergic innervation.
about
The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigmaSmall GTPase RhoG is a key regulator for neurite outgrowth in PC12 cellsReceptor protein tyrosine phosphatases in nervous system developmentProtein-tyrosine phosphatase (PTP) wedge domain peptides: a novel approach for inhibition of PTP function and augmentation of protein-tyrosine kinase functionOverexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistanceLeukocyte common antigen-related phosphatase is a functional receptor for chondroitin sulfate proteoglycan axon growth inhibitorsWithin the hemopoietic system, LAR phosphatase is a T cell lineage-specific adhesion receptor-like protein whose phosphatase activity appears dispensable for T cell development, repertoire selection and function.Neural stem cells from protein tyrosine phosphatase sigma knockout mice generate an altered neuronal phenotype in culture.Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formationIntracellular signaling pathways that regulate dendritic spine morphogenesis.Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma.Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases.Coordinated action of protein tyrosine phosphatases in insulin signal transduction.Role of CSPG receptor LAR phosphatase in restricting axon regeneration after CNS injuryImpaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient miceReceptor type protein tyrosine phosphatases (RPTPs) - roles in signal transduction and human disease.CRYP-2/cPTPRO is a neurite inhibitory repulsive guidance cue for retinal neurons in vitroA serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryoSALM5 trans-synaptically interacts with LAR-RPTPs in a splicing-dependent manner to regulate synapse developmentProtein tyrosine phosphatases: functional inferences from mouse models and human diseases.Scar-mediated inhibition and CSPG receptors in the CNS.Protein tyrosine phosphatase σ in proteoglycan-mediated neural regeneration regulation.Molecular mechanisms of scar-sourced axon growth inhibitorsDifferential effects of leukocyte common antigen-related protein on biochemical and biological activities of RET-MEN2A and RET-MEN2B mutant proteins.Leukocyte antigen-related protein tyrosine phosphatase negatively regulates hydrogen peroxide-induced vascular smooth muscle cell apoptosisDelayed peripheral nerve regeneration and central nervous system collateral sprouting in leucocyte common antigen-related protein tyrosine phosphatase-deficient mice.The p75 neurotrophin receptor has nonapoptotic antineurotrophic actions in the basal forebrain.Progressive changes in adherens junction structure during intestinal adenoma formation in Apc mutant mice.Protein tyrosine phosphatase sigma-deficient mice show aberrant cytoarchitecture and structural abnormalities in the central nervous system.Apparent normal lung architecture in protein tyrosine phosphatase-sigma-deficient mice.Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action.Leukocyte antigen-related deficiency enhances insulin-like growth factor-1 signaling in vascular smooth muscle cells and promotes neointima formation in response to vascular injury.Presenilin/gamma-secretase-mediated cleavage regulates association of leukocyte-common antigen-related (LAR) receptor tyrosine phosphatase with beta-catenin.The mouse Ptprr gene encodes two protein tyrosine phosphatases, PTP-SL and PTPBR7, that display distinct patterns of expression during neural development.
P2860
Q24523712-41357054-6AFE-43E7-BB79-F8DBE3C0C04EQ24551209-6DA33194-EFDC-48E5-BA47-EC9A790AFB5FQ28198681-A72B1E6E-9ED1-481D-806A-3704BE701150Q28307065-998BAA93-7BD2-4018-82FC-EF11BFBDA109Q28363155-FD48B5A7-A089-467C-9CD9-CC279CA63739Q28511924-1701524C-1A93-49DC-BD29-857A2D5D62E1Q32159773-1BA33E47-3A5E-4B12-8A83-691ABDC24E21Q33247223-9EC983CC-1E7B-4416-9C27-AE5FAC52BCCCQ33810171-21D8D393-8A2D-46B3-A1C6-DF3D6A0C9C90Q34081322-372241A2-71F5-437A-9C4B-03BAEFD4039DQ34323875-FE403AE3-7BA3-4E3E-A093-E60CF81A8951Q34388740-89797314-048D-41B8-83E3-8F5797D40824Q34539371-60E0C6AC-B408-4281-AFEB-4FFB94A322C1Q35592121-51837124-D1A4-49E2-A8D7-44C8624CDC0BQ36080560-4C57D380-A531-4783-A7F9-DD592FDBDFA0Q36170039-814E8E9B-D9FC-4716-B260-D112E729E785Q36377653-7A53DF2C-35B9-4482-ADD7-8CC3D275B491Q36785035-CCB28168-9D8A-497B-9052-9D4D145C57F0Q36937704-3D7E0954-7A35-43AC-800F-DAFE642E7D12Q37094061-E2FE7575-3D99-4E26-A7BC-F8EF2E0807F6Q38029901-639A9751-051A-44B1-A6D1-35C296D80203Q38041489-25CCAEB4-5BD7-470B-A874-C3F92E16C0E2Q38246350-E23103EA-E9C7-4072-8F6A-EFBA9453C64FQ40835424-57134907-77D2-450B-9DC0-24371E7DF451Q41502830-7EBC24A1-8E61-45D9-9EB4-6BB6AD3DD3EFQ42438711-6E6BEB24-46E5-4730-8B74-E415984A76A9Q42494540-DF3046D6-A055-4529-A9CC-FEB93ACB14C1Q43694398-EA8804D7-EE39-498B-9036-A0F41018C9CDQ44141724-E9F535DA-399E-458D-B4ED-7C9BBD305F40Q44241885-4195406F-3349-4E42-B977-22D888E6E678Q44805566-7FBAD0EA-1E20-4764-94D4-C7983EE338EDQ51471344-5ACC587A-1CB0-4DD7-98B5-B358285DEF71Q51800216-0948D439-666B-4774-834E-4B394E8070D4Q52172816-FDD98E55-DAEA-442A-82AA-974049D8D182
P2860
Deficient LAR expression decreases basal forebrain cholinergic neuronal size and hippocampal cholinergic innervation.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Deficient LAR expression decre ...... ampal cholinergic innervation.
@en
Deficient LAR expression decre ...... ampal cholinergic innervation.
@nl
type
label
Deficient LAR expression decre ...... ampal cholinergic innervation.
@en
Deficient LAR expression decre ...... ampal cholinergic innervation.
@nl
prefLabel
Deficient LAR expression decre ...... ampal cholinergic innervation.
@en
Deficient LAR expression decre ...... ampal cholinergic innervation.
@nl
P2093
P2860
P1476
Deficient LAR expression decre ...... ampal cholinergic innervation.
@en
P2093
J Honkaniemi
L L Butcher
P2860
P304
P356
10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y
P577
1997-02-01T00:00:00Z